Ctc Alternative Strategies, Ltd. Abbott Laboratories Transaction History

Ctc Alternative Strategies, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$100.73 - $112.44 $821,755 - $917,285	-8,158 Reduced 60.62%	5,300 $551 Million
Q1 2024 May 09, 2024	BUY	$109.52 - $120.96 $1.47 Million - $1.63 Million	13,458 New	13,458 $1.53 Billion
Q2 2023 Aug 23, 2023	BUY	$100.78 - $112.29 $312,418 - $348,099	3,100 New	3,100 $338 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Ctc Alternative Strategies, Ltd., based on Form 13F filings with the SEC.

Stay updated on Ctc Alternative Strategies, Ltd. with notifications on news.